| Primary |
| Contraception |
31.5% |
| Oral Contraception |
16.7% |
| Psoriasis |
11.1% |
| Headache |
7.4% |
| Torticollis |
7.4% |
| Epilepsy |
5.6% |
| Depression |
3.7% |
| Multiple Sclerosis |
3.7% |
| Off Label Use |
3.7% |
| Endometriosis |
1.9% |
| Insomnia |
1.9% |
| Menstruation Irregular |
1.9% |
| Onychomycosis |
1.9% |
| Osteomyelitis |
1.9% |
|
| Cerebral Infarction |
10.7% |
| Paresis |
10.7% |
| Cytolytic Hepatitis |
7.1% |
| Drug Ineffective |
7.1% |
| Paraplegia |
7.1% |
| Unintended Pregnancy |
7.1% |
| Acute Febrile Neutrophilic Dermatosis |
3.6% |
| Affective Disorder |
3.6% |
| Anaemia |
3.6% |
| Cholangitis |
3.6% |
| Colitis Ischaemic |
3.6% |
| Feeling Abnormal |
3.6% |
| Inflammation |
3.6% |
| Liver Function Test Abnormal |
3.6% |
| Muscle Spasms |
3.6% |
| Myopathy |
3.6% |
| Pruritus |
3.6% |
| Renal Vein Thrombosis |
3.6% |
| Social Phobia |
3.6% |
| Spinal Cord Ischaemia |
3.6% |
|
| Secondary |
| Product Used For Unknown Indication |
27.0% |
| Contraception |
14.8% |
| Oral Contraception |
9.8% |
| Psoriasis |
9.8% |
| Bipolar Disorder |
4.9% |
| Depression |
4.9% |
| Constipation |
4.1% |
| Drug Use For Unknown Indication |
4.1% |
| Torticollis |
3.3% |
| Type 2 Diabetes Mellitus |
3.3% |
| Sciatica |
2.5% |
| Acne |
1.6% |
| Migraine |
1.6% |
| Off Label Use |
1.6% |
| Smoking Cessation Therapy |
1.6% |
| Therapeutic Skin Care Topical |
1.6% |
| Congenital Condyloma |
0.8% |
| Crohn's Disease |
0.8% |
| Endometriosis |
0.8% |
| Epilepsy |
0.8% |
|
| Acute Respiratory Distress Syndrome |
11.1% |
| Pancreatitis Acute |
11.1% |
| Thrombophlebitis |
8.3% |
| Thrombosis |
8.3% |
| Vomiting |
8.3% |
| Eosinophilic Pneumonia |
5.6% |
| Liver Function Test Abnormal |
5.6% |
| Paresis |
5.6% |
| Social Phobia |
5.6% |
| Abdominal Pain Upper |
2.8% |
| Acute Febrile Neutrophilic Dermatosis |
2.8% |
| Colitis Ischaemic |
2.8% |
| Corneal Deposits |
2.8% |
| Dyspnoea |
2.8% |
| Erythema Multiforme |
2.8% |
| Hepatitis |
2.8% |
| Libido Decreased |
2.8% |
| Mass |
2.8% |
| Mobility Decreased |
2.8% |
| Muscle Spasms |
2.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.3% |
| Drug Use For Unknown Indication |
12.4% |
| Contraception |
10.2% |
| Depression |
6.5% |
| Epilepsy |
6.2% |
| Hypertension |
5.8% |
| Oral Contraception |
5.1% |
| Tuberculosis |
4.4% |
| Psoriasis |
4.0% |
| Crohn's Disease |
3.6% |
| Acne |
3.3% |
| Multiple Sclerosis |
2.9% |
| Hiv Infection |
2.5% |
| Eczema |
2.2% |
| Juvenile Arthritis |
2.2% |
| Sleep Disorder |
2.2% |
| Anaemia |
1.8% |
| Breast Cancer |
1.8% |
| Constipation |
1.8% |
| Pain |
1.8% |
|
| Vaginal Fistula |
13.8% |
| Urinary Tract Infection |
10.8% |
| Pulmonary Embolism |
6.2% |
| Toxic Skin Eruption |
6.2% |
| Weight Decreased |
6.2% |
| White Blood Cell Count Increased |
6.2% |
| Drug Exposure During Pregnancy |
4.6% |
| Social Phobia |
4.6% |
| Vision Blurred |
4.6% |
| Weight Increased |
4.6% |
| Wound Dehiscence |
4.6% |
| Cytolytic Hepatitis |
3.1% |
| Hepatic Failure |
3.1% |
| Hypertension |
3.1% |
| Maternal Drugs Affecting Foetus |
3.1% |
| Paresis |
3.1% |
| Progressive Multifocal Leukoencephalopathy |
3.1% |
| Severe Acute Respiratory Syndrome |
3.1% |
| Thyroid Neoplasm |
3.1% |
| Tongue Disorder |
3.1% |
|
